FDG PET/CT in infection and inflammation - Current and emerging clinical applications

Clinical Radiology

Volumn 70, Issue 7, 2015, Pages 787-800

  Vaidyanathan, S ^a   Patel, C N ^a   Scarsbrook, A F ^a   Chowdhury, F U ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

BLOOD VESSEL GRAFT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETIC FOOT; GRAFT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLAMMATION; INTERMETHOD COMPARISON; JOINT PROSTHESIS; MEDICAL DEVICE COMPLICATION; OSTEOMYELITIS; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; REVIEW; SARCOIDOSIS; SYSTEMATIC REVIEW (TOPIC); VASCULITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; EVIDENCE BASED MEDICINE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROCEDURES; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

EVIDENCE-BASED MEDICINE; FLUORODEOXYGLUCOSE F18; HUMANS; INFECTION; INFLAMMATION; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84930757544     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2015.03.010     Document Type: Review

References (114)

1. F. Jamar, J. Buscombe, and A. Chiti EANM/SNMMI guideline for 18F-FDG use in inflammation and infection J Nucl Med 54 4 2013 647 658
2. T.M. Blodgett, C.C. Meltzer, and D.W. Townsend PET/CT: form and function Radiology 242 2 Feb 2007 360 385
3. R. Smith-Bindman, D.L. Miglioretti, and E. Johnson Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010 JAMA 307 22 2012 2400 2409
4. G.K. von Schulthess, H.C. Steinert, and T.F. Hany Integrated PET/CT: current applications and future directions Radiology 238 2 2006 405 422
5. B.E. Hillner, B.A. Siegel, and A.F. Shields The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry Cancer 115 2 2009 410 418
6. M. Hashefi, and R. Curiel Future and upcoming non-neoplastic applications of PET/CT imaging Ann NY Acad Sci 1228 2011 167 174
7. O. Warburg Metabolism of tumours Biochem Z 142 1923 317 333
8. R. Kubota, S. Yamada, and K. Kubota Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 11 1992 1972 1980
9. L.A. O'Neill, and D.G. Hardie Metabolism of inflammation limited by AMPK and pseudo-starvation Nature 493 7432 Jan 17 2013 346 355
10. T. Mochizuki, E. Tsukamoto, and Y. Kuge FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models J Nucl Med 42 10 2001 1551 1555
11. K. Ohba, S. Sasaki, and Y. Oki Factors associated with fluorine-18-fluorodeoxyglucose uptake in benign thyroid nodules Endocrine J 60 8 2013 985 990
12. S. Basu, T.C. Kwee, and S. Surti Fundamentals of PET and PET/CT imaging Ann NY Acad Sci 1228 2011 1 18
13. E.K. Pauwels, M.J. Ribeiro, and J.H. Stoot FDG accumulation and tumor biology Nucl Med Biol 25 4 1998 317 322
14. L.R. Sorbara, F. Maldarelli, and G. Chamoun Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression J Virol 70 10 1996 7275 7279
15. M. Bental, and C. Deutsch Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes Magn Reson Med 29 3 1993 317 326
16. S. Marjanovic, S. Skog, and T. Heiden Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry Exp Cell Res 193 2 1991 425 431
17. I.M. Irmler, T. Opfermann, and P. Gebhardt In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography Arthritis Res Ther 12 6 2010 R203
18. V. Goh, M. Shastry, and A. Engledow Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters AJR Am J Roentgenol 199 5 2012 1003 1009
19. Y.E. Huang, C.F. Chen, and Y.J. Huang Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors Acta Radiol 51 7 2010 782 788
20. The Royal College of Physicians and the Royal College of Radiologists Evidence-based indications for the use of PET-CT in the UK 2013 RCP, RCR London
21. O. Mourad, V. Palda, and A.S. Detsky A comprehensive evidence-based approach to fever of unknown origin Arch Intern Med 163 5 2003 545 551
22. R.G. Petersdorf, and P.B. Beeson Fever of unexplained origin: report on 100 cases Medicine 40 1961 1 30
23. R.G. Petersdorf Fever of unknown origin. An old friend revisited Arch Intern Med 152 1 1992 21 22
24. D.T. Durack, and A.C. Street Fever of unknown origin - reexamined and redefined Curr Clin Top Infect Dis 11 1991 35 51
25. C.P. Bleeker-Rovers, F.J. Vos, and A.H. Mudde A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin Eur J Nucl Med Mol Imaging 34 5 2007 694 703
26. C.P. Bleeker-Rovers, E.M. de Kleijn, and F.H. Corstens Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation Eur J Nucl Med Mol Imaging 31 1 2004 29 37
27. I. Buysschaert, S. Vanderschueren, and D. Blockmans Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin Eur J Intern Med 15 3 2004 151 156
28. J. Meller, G. Altenvoerde, and U. Munzel Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET Eur J Nucl Med 27 11 2000 1617 1625
29. H. Balink, J. Collins, and G.A. Bruyn F-18 FDG PET/CT in the diagnosis of fever of unknown origin Clin Nucl Med 34 12 2009 862 868
30. Z. Keidar, A. Gurman-Balbir, and D. Gaitini Fever of unknown origin: the role of 18F-FDG PET/CT J Nucl Med 49 12 2008 1980 1985
31. I.J.E. Kouijzer, C.P. Bleeker-Rovers, and W. Oyen FDG-PET in fever of unknown origin Semin Nucl Med 43 2013 333 339
32. A.D. Culverwell, A.F. Scarsbrook, and F.U. Chowdhury False-positive uptake on 2-[(1)(8)F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging Clin Radiol 66 4 Apr 2011 366 382
33. E. Even-Sapir, Z. Keidar, and R. Bar-Shalom Hybrid imaging (SPECT/CT and PET/CT)-improving the diagnostic accuracy of functional/metabolic and anatomic imaging Semin Nucl Med 39 4 2009 264 275
34. G.G. Hunder, W.P. Arend, and D.A. Bloch The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction Arthritis Rheum 33 8 1990 1065 1067
35. J.C. Jennette, R.J. Falk, and K. Andrassy Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 2 1994 187 192
36. B. Dasgupta, F.A. Borg, and N. Hassan BSR and BHPR guidelines for the management of giant cell arteritis Rheumatology 49 8 2010 1594 1597
37. D. Blockmans PET in vasculitis Ann NY Acad Sci 1228 2011 64 70
38. C. Mukhtyar, L. Guillevin, and M.C. Cid EULAR recommendations for the management of large vessel vasculitis Ann Rheum Dis 68 3 2009 318 323
39. E.W. Chong, and A.J. Robertson Is temporal artery biopsy a worthwhile procedure? ANZ J Surg 75 6 2005 388 391
40. A. Brack, V. Martinez-Taboada, and A. Stanson Disease pattern in cranial and large-vessel giant cell arteritis Arthritis Rheum 42 2 1999 311 317
41. J. Theron, and J.L. Tyler Takayasu's arteritis of the aortic arch: endovascular treatment and correlation with positron emission tomography AJNR Am J Neuroradiol 8 4 1987 621 626
42. D. Blockmans, D. Knockaert, and A. Maes Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin Clin Infect Dis 32 2 2001 191 196
43. D. Blockmans, A. Maes, and S. Stroobants New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography Rheumatology 38 5 1999 444 447
44. M. Both, K. Ahmadi-Simab, and M. Reuter MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis Ann Rheum Dis 67 7 2008 1030 1033
45. M. Fuchs, M. Briel, and T. Daikeler The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis Eur J Nucl Med Mol Imaging 39 2 2012 344 353
46. S.G. Lee, J.S. Ryu, and H.O. Kim Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis Clin Nucl Med 34 11 2009 749 752
47. 18F-FDG PET as a diagnostic procedure in large vessel vasculitis - a controlled, blinded re-examination of routine PET scans Clin Rheumatol 30 1 2011 37 42
48. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters Br J Radiol 85 1014 2012 e188 194
49. M.A. Walter, R.A. Melzer, and C. Schindler The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease Eur J Nucl Med Mol Imaging 32 6 2005 674 681
50. G. Treglia, M.V. Mattoli, and L. Leccisotti Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review Clin Rheumatol 30 10 2011 1265 1275
51. F.L. Besson, J.J. Parienti, and B. Bienvenu Diagnostic performance of (1)(8)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis Eur J Nucl Med Mol Imaging 38 9 2011 1764 1772
52. H. Hautzel, O. Sander, and A. Heinzel Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio J Nucl Med 49 7 2008 1107 1113
53. D. Blockmans, L. De Ceuninck, and S. Vanderschueren Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients Rheumatology 46 4 2007 672 677
54. S. Karunanithi, P. Sharma, and C. Bal (18)F-FDG PET/CT for diagnosis and treatment response evaluation in large vessel vasculitis Eur J Nucl Med Mol Imaging 41 3 2014 586 587
55. I. Zeriser, K. Tan, and S. Khan Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis Eur J Radiol 73 3 2010 504 509
56. E. Zetrenne, B.C. McIntosh, and M.H. McRae Prosthetic vascular graft infection: a multi-center review of surgical management Yale J Biol Med 80 3 2007 113 121
57. J.M. Seeger Management of patients with prosthetic vascular graft infection Am Surg 66 2 2000 166 177
58. Z. Keidar, N. Pirmisashvili, and M. Leiderman 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time J Nucl Med 55 3 2014 392 395
59. M. Spacek, O. Belohlavek, and J. Votrubova Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses Eur J Nucl Med Mol Imaging 36 5 2009 850 858
60. Z. Keidar, A. Engel, and A. Hoffman Prosthetic vascular graft infection: the role of 18F-FDG PET/CT J Nucl Med 48 8 2007 1230 1236
61. G.W. Hunninghake, U. Costabel, and M. Ando ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 16 2 1999 149 173
62. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 21 2007 2153 2165
63. P.R. Studdy, and R. Bird Serum angiotensin converting enzyme in sarcoidosis - its value in present clinical practice Ann Clin Biochem 26 Pt 1 1989 13 18
64. H. Nunes, P.Y. Brillet, and D. Valeyre Imaging in sarcoidosis Semin Resp Crit Care Med 28 1 2007 102 120
65. A.S. Teirstein, J. Machac, and O. Almeida Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis Chest 132 6 2007 1949 1953
66. J.J. Braun, R. Kessler, and A. Constantinesco 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases Eur J Nucl Med Mol Imaging 35 8 2008 1537 1543
67. D.P. Sobic-Saranovic, I.T. Grozdic, and J. Videnovic-Ivanov Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis Clin Nucl Med 38 7 2013 516 521
68. D. Sobic-Saranovic, V. Artiko, and V. Obradovic FDG PET imaging in sarcoidosis Semin Nucl Med 43 6 2013 404 411
69. R.L. Mostard, J.A. Verschakelen, and M.J. van Kroonenburgh Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis Resp Med 107 3 2013 439 447
70. M.A. Shafee, K. Fukuda, and Y. Wakayama Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis J Cardiol 60 6 2012 448 453
71. I. Schatka, and F.M. Bengel Advanced imaging of cardiac sarcoidosis J Nucl Med 55 1 2014 99 106
72. B.A. Mc Ardle, E. Leung, and H. Ohira The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis J Nucl Cardiol 20 2 2013 297 306
73. R. Coulden, P. Chung, and E. Sonnex Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet Eur Radiol 22 10 2012 2221 2228
74. 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease J Thorac Imaging 27 4 2012 263 268
75. 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2 2012 241 248
76. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 5 2008 933 941
77. D.S. Schauwecker The scintigraphic diagnosis of osteomyelitis AJR Am J Roentgenol 158 1 1992 9 18
78. W. van der Bruggen, C.P. Bleeker-Rovers, and O.C. Boerman PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review Semin Nucl Med 40 1 2010 3 15
79. G. El-Haddad, H. Zhuang, and N. Gupta Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders Semin Nucl Med 34 4 2004 313 329
80. M.F. Termaat, P.G. Raijmakers, and H.J. Scholten The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis J Bone Joint Surg Am 87 11 2005 2464 2471
81. G.L. Wang, K. Zhao, and Z.F. Liu A meta-analysis of fluorodeoxyglucose-positron emission tomography versus scintigraphy in the evaluation of suspected osteomyelitis Nucl Med Comm 32 12 2011 1134 1142
82. A. Guhlmann, D. Brecht-Krauss, and G. Suger Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis J Nucl Med 39 12 1998 2145 2152
83. F. de Winter, C. van de Wiele, and D. Vogelaers Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections J Bone Joint Surg Am 83-a 5 2001 651 660
84. H. Zhuang, J.W. Sam, and T.K. Chacko Rapid normalization of osseous FDG uptake following traumatic or surgical fractures Eur J Nucl Med Mol Imaging 30 8 2003 1096 1103
85. A. Hartmann, K. Eid, and C. Dora Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis Eur J Nucl Med Mol Imaging 34 5 2007 704 714
86. M. Schiesser, K.D. Stumpe, and O. Trentz Detection of metallic implant-associated infections with FDG PET in patients with trauma: correlation with microbiologic results Radiology 226 2 2003 391 398
87. C.J. Palestro FDG-PET in musculoskeletal infections Semin Nucl Med 43 5 2013 367 376
88. K.D. Stumpe, M. Zanetti, and D. Weishaupt FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging AJR Am J Roentgenol 179 5 2002 1151 1157
89. S.M. Kurtz, E. Lau, and J. Schmier Infection burden for hip and knee arthroplasty in the United States J Arthroplasty 23 7 2008 984 991
90. C. Love, S.E. Marwin, and C.J. Palestro Nuclear medicine and the infected joint replacement Semin Nucl Med 39 1 2009 66 78
91. C.J. Palestro, C.K. Kim, and A.J. Swyer Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection J Nucl Med 31 12 1990 1950 1955
92. L. Mulamba, A. Ferrant, and N. Leners Indium-111 leucocyte scanning in the evaluation of painful hip arthroplasty Acta Orthopaed Scand 54 5 1983 695 697
93. A. Kapoor, S. Page, and M. Lavalley Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis Arch Intern Med 167 2 2007 125 132
94. S. Basu, T. Chryssikos, and S. Moghadam-Kia Positron emission tomography as a diagnostic tool in infection: present role and future possibilities Semin Nucl Med 39 1 2009 36 51
95. G. Treglia, R. Sadeghi, and S. Annunziata Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis Foot 23 4 2013 140 148
96. P. Piot, and T.C. Quinn Response to the AIDS pandemic - a global health model N Engl J Med 368 23 2013 2210 2218
97. S. Iyengar, B. Chin, and J.B. Margolick Anatomical loci of HIV-associated immune activation and association with viraemia Lancet 362 9388 2003 945 950
98. M. Sathekge, A. Maes, and M. Kgomo Fluorodeoxyglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count Nucl Med Comm 31 2 2010 137 140
99. C. Martin, C. Castaigne, and M. Tondeur Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study HIV Med 14 8 2013 455 462
100. K. Villringer, H. Jager, and M. Dichgans Differential diagnosis of CNS lesions in AIDS patients by FDG-PET J Comp Assist Tomogr 19 4 1995 532 536
101. J.M. Hoffman, H.A. Waskin, and T. Schifter FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS J Nucl Med 34 4 1993 567 575
102. F.J. Vos, C.P. Bleeker-Rovers, and W.J. Oyen The use of FDG-PET/CT in patients with febrile neutropenia Semin Nucl Med 43 5 Sep 2013 340 348
103. V. Deshpande, Y. Zen, and J.K. Chan Consensus statement on the pathology of IgG4-related disease Mod Pathol 25 9 2012 1181 1192
104. K. Nakatani, Y. Nakamoto, and K. Togashi Utility of FDG PET/CT in IgG4-related systemic disease Clin Radiol 67 4 2012 297 305
105. P.D. Shreve, Y. Anzai, and R.L. Wahl Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants RadioGraphics 19 1 1999 61-77; quiz 150-151
106. G. Treglia, N. Quartuccio, and R. Sadeghi Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis J Crohn Colitis 7 5 2013 345 354
107. N. Dumarey, D. Egrise, and D. Blocklet Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients J Nucl Med 47 4 2006 625 632
108. J.N. Rini, K.K. Bhargava, and G.G. Tronco PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection Radiology 238 3 2006 978 987
109. A. Bhattacharya, R. Kochhar, and K. Aggrawal 18F-FDG and FDG-labeled leukocyte PET/CT in peritoneal tuberculosis Clin Nucl Med 23 2013
110. A. Bhattacharya, R. Kochhar, and A. Khaliq Incidental detection of colonic inflammation on PET/CT using 18F-FDG-labeled autologous leukocytes Clin Nucl Med 38 2 2013 e101 102
111. S. Yilmaz, S. Asa, and M. Ozhan Graft infection imaging with FDG and FDG-labeled leukocytes Intern Med 52 9 2013 1009 1010
112. L.A. Forstrom, B.P. Mullan, and J.C. Hung 18F-FDG labelling of human leukocytes Nucl Med Commun 21 7 2000 691 694
113. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results J Nucl Med 51 12 2010 1932 1936
114. A. Roivainen, S. Jalkanen, and C. Nanni Gallium-labelled peptides for imaging of inflammation Eur J Nucl Med Mol Imaging 39 Suppl. 1 2012 S68 S77